Melanin for treating lipofuscin-associated diseases
AssigneeKatairo GmbH
InventorUlrich SCHRAERMEYER
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition for use in the treatment and/or prophylaxis of a lipofuscin-associated disease, wherein the composition comprises melanin and/or induces melanogenesis.
Claims10
A composition for use in the treatment of a lipofuscin-associated disease, wherein the composition comprises melanin and/or induces melanogenesis.
A composition for use in the treatment of a lipofuscin-associated disease, wherein the composition comprises a combination of melanin and/or a melanin inducing agent with a superoxide-generator and/or an NO-generator.
A composition for use in the treatment of a lipofuscin-associated disease, wherein the composition comprises a combination of melanin and/or a melanin inducing agent with soraprazan and/or ISDN.
Dependencies are inferred from the claim text.